Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2004
10/12/2004US6803453 Using antibodies directed to a novel class or family of transforming growth factor (tgf)-beta binding proteins; for diagnosis, prevention, treatment of osteoporosis
10/12/2004US6803449 Polypeptide for use in the diagnosis and treatment viral diseases
10/12/2004US6803361 Administering nucleotide sequence
10/12/2004US6803360 Resistance to said radiation or drug treatment is not a result of overexpression of her-2, comprising introducing into said cell an antisense nucleic acid
10/12/2004US6803238 Methods for multiplexed biochemical analysis
10/12/2004US6803234 Expression vector for use in the transduction of human chondrocyte; obtain chondrocytes, incubate with expression vector, monitor cell for expression of reporter molecule
10/12/2004US6803232 Neuropeptide y (npy) receptor (designated npy- y7) used to express the receptor in cells which can then be used for drug screening
10/12/2004US6803230 Containing a sequence of features between a col e1 origin and an f1 origin are useful for display of polypeptides or proteins, including antibody libraries
10/12/2004US6803228 Method for making a biochip and biochip
10/12/2004US6803225 Expression vector for use transformation of yeast cells
10/12/2004US6803224 Regulated expression of cloned genes using a cascade genetic circuit
10/12/2004US6803223 Plant branched-chain amino acid biosynthetic enzymes
10/12/2004US6803222 Alkaline proteases
10/12/2004US6803221 Comprises nucleotide sequences coding enzymatic polypeptides for use as drug screening, diagnostic and therapeutic tools; cosmetics; nutriceuticals
10/12/2004US6803218 Using thermophilic organisms; which catalytically ferment glycerol to 1,3-propanediol; cloning polynucleotides; solid phase synthesis
10/12/2004US6803216 Compositions and methods for random nucleic acid mutagenesis
10/12/2004US6803213 Having one or more amino acid substitutions that confer receptor agonist or antagonist properties
10/12/2004US6803212 Low oxygen affinity mutant hemoglobins
10/12/2004US6803211 Cancer therapy
10/12/2004US6803210 Methods and cells for expression of recombinant protein products under the transcriptional control of an inducible promoter
10/12/2004US6803204 Kinase for use in the treatment of cell proliferative, inflammatory and apoptotic disorders
10/12/2004US6803200 Compositions and methods for the release of nucleic acid molecules from solid matrices
10/12/2004US6803199 Thyroid sodium/iodide symporter and nucleic acid encoding same
10/12/2004US6803197 Method for determining susceptibility to bone damage by screening polymorphisms in the vitamin D receptor gene
10/12/2004US6803194 Generation of a specific cellular phenotype or a specific cellular response using combinatorial libraries; for disease therapy; zinc finger, protein kinase, integrin motifs
10/12/2004US6803189 Methods for the detection of cervical cancer
10/12/2004US6803188 Tandem fluorescent protein constructs
10/12/2004US6803187 Allowing the simultaneous charaterization of a range of codons involved in drug resistance using specific sets of probes optimized to function together in a reverse-hybridization assay; solid phase synthesis
10/12/2004US6803186 Compositions and methods for increasing amino acid absorption in mammals
10/12/2004US6803053 Condensed nucleic acid/lipid complex for increasing shelf life and high transfection activity in vivo following intravenous injection
10/12/2004US6803043 Basbo27 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
10/12/2004US6803039 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM
10/12/2004US6802966 Complex of metal oxide and alcohol
10/12/2004CA2391131C Genes and proteins for rosaramicin biosynthesis
10/12/2004CA2387401C Compositions, methods and systems for the production of enediynes
10/12/2004CA2216244C Als3 promoter
10/12/2004CA1341458C Modified human t-pa
10/11/2004CA2461106A1 Compositions and methods for genetic analysis of polycystic kidney disease
10/07/2004WO2004086055A1 Microchip, nucleic acid extracting kit, and nucleic acid extracting method
10/07/2004WO2004085680A1 Method of detecting target nucleotide sequence, detection target structure to be used in embodying the method, process for producing the same and assay kit for detecting target nucleotide sequence
10/07/2004WO2004085666A2 Secreted proteins
10/07/2004WO2004085665A2 Nucleic acid ligand to b. anthracis protective antigen
10/07/2004WO2004085660A2 Improved alphavirus replicons and helper constructs
10/07/2004WO2004085659A2 Mutant vesicular stomatitis viruses and uses thereof
10/07/2004WO2004085658A1 Mutant vesicular stomatitis viruses and use thereof
10/07/2004WO2004085657A1 A method for generating plant diversity by incorporation of microsatelllite sequences into the plant genome
10/07/2004WO2004085656A2 Enhanced accumulation of carotenoids in plants
10/07/2004WO2004085655A1 A plant expression plasmid or a transgenic plant cell line of hepatitis b viral gene, as well as the application thereof in the industrial production
10/07/2004WO2004085654A2 Modulation of cell phenotype by inhibitory rna
10/07/2004WO2004085652A1 Barley lipoxygenase 1 gene, method of selecting barley variety, material of malt alcoholic drinks and process for producing malt alcoholic drink
10/07/2004WO2004085650A1 A high-troughput diagnostic assay for the human virus causing severe acute respiratory syndrome (sars)
10/07/2004WO2004085649A1 Prfb factor (peptide chain release factor b) from bacillus licheniformis and the utilization thereof for enhancing the protein formation rate
10/07/2004WO2004085648A2 Nogo receptor binding protein
10/07/2004WO2004085647A1 Low-molecular weight peptides inhibiting ion channel activity
10/07/2004WO2004085646A1 Cyclic amp response element activator proteins and uses related thereto
10/07/2004WO2004085645A1 Rna interference in fish
10/07/2004WO2004085644A2 Method for producing recombinant organisms
10/07/2004WO2004085643A1 Methods and devices for producing biomolecules
10/07/2004WO2004085641A1 Stress-induced promoter and method of using the same
10/07/2004WO2004085635A1 Melan-a peptide analogue-virus-like-particle conjugates
10/07/2004WO2004085629A1 Process for producing glucose dehydrogenase
10/07/2004WO2004085627A1 New saccharomyces cerevisiae strains utilizing xylose
10/07/2004WO2004085623A2 A compact synthetic expression vector comprising double-stranded dna molecules and methods of use thereof
10/07/2004WO2004085620A2 Novel attached cell lines
10/07/2004WO2004085619A2 Expression of desirable proteins in plant roots and cell cultures
10/07/2004WO2004085618A2 Method of screening for target ligands
10/07/2004WO2004085615A2 Glucosidases, nucleic acids encoding them and methods for making and using them
10/07/2004WO2004085613A2 Electrocompetent host cells
10/07/2004WO2004085608A2 Methods for high throughput elucidation of transcriptional profiles and genome annotation
10/07/2004WO2004085607A2 Texturizing lactic bacteria
10/07/2004WO2004085472A1 Method for making human insulin precursors and human insulin
10/07/2004WO2004085470A1 Interferon-alpha induced gene
10/07/2004WO2004085469A2 Secreted protein family
10/07/2004WO2004085468A2 Human p53 splice variant displaying differential transcriptional activity
10/07/2004WO2004085463A2 Methods of unnatural amino acid incorporation in proteins in mammalian cells
10/07/2004WO2004085456A1 Compositions and methods for identifying genes whose products modulate biological processes
10/07/2004WO2004084951A2 A method and vectors for selectively transducing retinal pigment epithelium cells
10/07/2004WO2004084945A1 Eating controllers
10/07/2004WO2004084942A2 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18)
10/07/2004WO2004084940A1 Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use
10/07/2004WO2004084939A2 Hiv-peptide-carrier-conjugates
10/07/2004WO2004084874A2 Mtp inhibitors for inhibiting inflammation
10/07/2004WO2004084831A2 Optimized expression of hpv 31 l1 in yeast
10/07/2004WO2004084821A2 Hemipteran glutamate decarboxylase
10/07/2004WO2004084815A2 Virulence genes of h. pylori in gastric cancer
10/07/2004WO2004084810A2 Novel imidazoline receptor homologs
10/07/2004WO2004084797A2 Type 2 diabetes mellitus-associated gene and utilization of the same
10/07/2004WO2004084705A2 Quantitative detection of h. pylori in biological samples
10/07/2004WO2004069999A3 Screening method
10/07/2004WO2004069997A3 Method for the production of a composition of dna sequences or the expression products thereof permitting the identification of the strains of helicobacter pylori and use thereof in a prognostic or diagnostic method
10/07/2004WO2004067750A3 Xenorhabdus tc proteins and genes for pest control
10/07/2004WO2004067701A3 Improved genetic elements providing high levels of expression
10/07/2004WO2004067698A3 Helminth-derived antigens having capacity of providing protection against parasites
10/07/2004WO2004067568A3 Human il-1 beta antagonists
10/07/2004WO2004067549A3 Peptides directed against antibodies, which cause cold-intolerance, and the use thereof
10/07/2004WO2004065613A3 Inducible small interfering rna (sirna) expression constructs for targeted gene silencing
10/07/2004WO2004064714A3 Animal model for obesity independently of insulin resistance
10/07/2004WO2004058947A3 Steroid receptor modulation of gene expression
10/07/2004WO2004055178A9 Thermostable alpha-amylases
10/07/2004WO2004055162A3 Modulation of endothelial lipase expression